Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture

PURPOSE: To compare the safety profiles of antivascular endothelial growth factor (VEGF) drugs ranibizumab, bevacizumab, aflibercept and ziv-aflibercept on retinal pigment epithelium cells in culture. METHODS: Human retinal pigment epithelium cells (ARPE-19) were exposed for 24 h to four anti-VEGF d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Malik, Deepika, Tarek, Mohamed, Caceres del Carpio, Javier, Ramirez, Claudio, Boyer, David, Kenney, M Cristina, Kuppermann, Baruch D
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2014
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4033208/
https://ncbi.nlm.nih.gov/pubmed/24836865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2014-305302
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados